DAFTAR PUSTAKA 1 In: Sulistia Gan Gunawan (eds.) Farmakologi

Farmakologi dan Terapi, 5th ed. Jakarta: FK Universitas ... 4. J. A. Alhashemi and M. F. Daghistani. Effects of intraoperative i.v acetaminophen vs i...

197 downloads 384 Views 2MB Size
41

DAFTAR PUSTAKA 1

In: Sulistia Gan Gunawan (eds.) Farmakologi dan Terapi, 5th ed. Jakarta: FK Universitas Indonesia; 2008. p230-246

2

Toms L, McQuay HJ, Derry S, Moore RA. Single Dose Oral Paracetamol (Acetaminophen) For Postoperative Pain in Adults. The Cochrane Collaboration. 20012;(6)

3

Adnan Asaad Abu omar, Khaled Awwad Al issa. Intravenous paracetamol (Prefalgan) for analgesia after cesarean section. Rawal Medical Journal.2011;36(4)

4

J. A. Alhashemi and M. F. Daghistani. Effects of intraoperative i.v acetaminophen vs i.m meperidine on post-tonsillectomy pain in children. British Journal of Anaesthesia.2006;(6)

5

Heirmayani. Toksikopatologi Hati Mencit Pada Pemberian Parasetamol. IPB. 2007

6

Paramita, P. Kadar Serum Aspartat Aminotransferase dan Alanin Aminotransferase Pada Tikus Wistar Setelah Pemberian Asetaminofen Per Oral Dalam Berbagai Dosis. Semarang: UNDIP. 2007

7

Moynihan, R. FDA fails to reduce accessibility of paracetamol despite 450 deaths a year. BMJ; 2002. p325-678

8

Siker BPOM. Data keracunan parasetamol di Indonesia tahun 20022005.BPOM. 2006

9

Soenarjo (eds.). Anestesiologi. Semarang: IDSAI Cabang Jawa Tengah. 2002; p295-309

42

10

Sherlock, S. Penyakit Hati dan Sistem Saluran Empedu. Jakarta: Widya Medika. 1995;p145-167

11

Departemen Pendidikan Nasional. Kamus Besar Bahasa Indonesia [internet].

[cited

2013

februari

9].

Available

from:

http://bahasa.kemdiknas.go.id/kbbi/index.php Susilaningsih, 12

Boulton, T.B. Anestesiologi, Edisi 10. Jakarta: EGC. 2004;p120-122

13

Latief, S.A. et al. Petunjuk Praktis Anestesiologi. Jakarta: Bag. Anestesiologi dan Terapi intensif FK UI. 2002;p86-90

14

Katzung, B.G. Farmakologi Dasar dan Klinik. Jakarta: Salemba Medika. 2004;p479-489

15

Dorland. Kamus Kedokteran Dorland. Jakarta: EGC. 2008;p.(n)

16

Price, S.A et al. Patofisiologi vol. 1. Jakarta: EGC. 2005;p457-515

17

Bagian Anatomi. Situs Abdominis. Semarang: Bagian Anatomi, Fakultas Kedokteran Universitas Diponegoro

18

Leeson S.T. et al. Buku Ajar Histologi. Jakarta: EGC. 2003

19

Neni. Lecture Notes Histologi 2. Semarang: Bagian Histologi Fakultas Kedokteran UNDIP. 2010

20

Aru W dkk. Ilmu Penyakit Dalam Jilid 1 Edisi V. Jakarta: InternaPublishing. 2009;p640-688

21

Marshall, W. Alanine Aminotranferase (Serum, Plasma). The Association for Clinical Biochemistry. 2012

22

Guyton and Hall. Textbook Of Medical Physiology. Jakarta:EGC.1997;

23

Girindra A. Patologi Klinik. Bogor:IPB. 1986

43

24

Frank C. Toksikologi Dasar, Edisi 2. Jakarta: Balai Penerbit FK UI. 1995;p111-113

25

Julita, I. Aspek Farmakokinetik Klinik Beberapa Obat Berpotensi Hepatotoksik Pada Pasien Rawat Inap di Bangsal Paru RSUP Dr. M. Djamil Padang.2011

26

World

Health

Organization

(WHO).

General

Guidelines

for

Methodologies on Research and Evaluation of Traditional Medicine. Geneva: WHO. 2000 27

Laurence, D.R. et al. Evaluation of Drug Activities. London: Academic Press.1964

28

LeeWM,

Ostapowicz

G.

Acetaminophen

:

Pathology

and

clinicalpresentations of hepatotoxicity. In: Kaplowitz N, DeLeve LD, editors. DrugInduced Liver Injury. Informa Healthcare USA, 2007 29

Nelson SD, Bruschi SA. Mechanisms of acetaminophen induced liverdamage. In: Kaplowitz N, DeLeve LD, editors. Drug Induced Liver Injury.Informa Healthcare USA, 2007

30

MedlinePlus [internet]. United State: SGPT/ALT; 2011 [update 2013 Feb 2; cited 2013 Jul 31]. Available from: http://www.webmd.com/digestivedisorders/alanine-aminotransferase-alt?page=2

31

E, Kosasih dan A.S Kosasih. Tafsiran hasil pemeriksaan laboratorium klinik, Edisi 2. Tangerang: Karishma Publishing Group; 2008;p150-152

LAMPIRAN

44

LAMPIRAN 1. ETHICAL CLEARANCE

LAMPIRAN 2. SURAT IJIN PENELITIAN

45

LAMPIRAN 3. HASIL PENELITIAN

46

Case Processing Summary

Cases

kadar SGPT

kadar SGPT

pemberian parasetamol KONTROL PERLAKUAN 1 PERLAKUAN 2

pemberian parasetamol KONTROL

N

Valid Percent 5 100.0% 5 100.0% 5 100.0% Descriptives

N

Missing Percent 0 .0% 0 .0% 0 .0%

Total Percent 5 100.0% 5 100.0% 5 100.0%

Statistic Mean 95% Confidence Interval for Mean

67.780 Lower Bound Upper Bound

67.794 68.500

Variance

48.297

Std. Deviation

6.9496

Minimum

59.7

Maximum

75.6

Range

15.9 13.7

Skewness Kurtosis Mean

5% Trimmed Mean Median

3.1080

76.409

Median

95% Confidence Interval for Mean

Std. Error

59.151

5% Trimmed Mean

Interquartile Range

PERLAKUAN 1

N

Lower Bound Upper Bound

-.117

.913

-2.529

2.000

90.540

7.3971

70.002 111.078 90.544 95.700

Variance

273.588

Std. Deviation

16.5405

Minimum

71.5

Maximum

109.5

Range

38.0

Interquartile Range

31.9

47

Skewness PERLAKUAN 2

-.232

.913

Kurtosis

-2.494

2.000

Mean

98.560

9.2999

95% Confidence Interval for Mean

Lower Bound

72.739

Upper Bound

124.381

5% Trimmed Mean

99.644

Median

107.700

Variance

432.443

Std. Deviation

20.7953

Minimum

63.2

Maximum

114.4

Range

51.2

Interquartile Range

32.4

Skewness Kurtosis

-1.750

.913

3.053

2.000

Tests of Normality Kolmogorov-Smirnov(a)

pemberian parasetamol KONTROL

kadar SGPT

Statistic

df

Shapiro-Wilk

Sig.

Statistic

Sig.

5

.200(*)

.922

5

.540

PERLAKUAN 1

.225

5

.200(*)

.906

5

.442

PERLAKUAN 2

.270

5

.200(*)

.804

5

.087

* This is a lower bound of the true significance. a Lilliefors Significance Correction

120.0

kadar SGPT

df

.205

100.0

80.0

11 60.0

KONTROL

PERLAKUAN 1

PERLAKUAN 2

pemberian parasetamol

48

Test of Homogeneity of Variances kadar SGPT Levene Statistic 1.850

df1

df2 2

Sig. .199

12

ANOVA kadar SGPT

Between Groups

Sum of Squares 2549.577

2

Mean Square 1274.789

Within Groups

3017.312

12

251.443

Total

5566.889

14

df

F 5.070

Sig. .025

Post Hoc Tests Multiple Comparisons Dependent Variable: kadar SGPT LSD (J) pemberian parasetamol

Mean Difference (IJ)

KONTROL

PERLAKUAN 1 PERLAKUAN 2

Lower Bound -22.7600(*) -30.7800(*)

Upper Bound 10.0288 10.0288

Lower Bound .042 .010

Upper Bound -44.611 -52.631

Lower Bound -.909 -8.929

PERLAKUAN 1

KONTROL

22.7600(*)

10.0288

.042

.909

44.611

-8.0200 30.7800(*) 8.0200 * The mean difference is significant at the .05 level.

10.0288 10.0288 10.0288

.439 .010 .439

-29.871 8.929 -13.831

13.831 52.631 29.871

(I) pemberian parasetamol

PERLAKUAN 2

PERLAKUAN 2

KONTROL PERLAKUAN 1

LAMPIRAN 4. DOKUMENTASI

Std. Error

Sig.

95% Confidence Interval

49

50

51

LAMPIRAN 5. DAFTAR RIWAYAT HIDUP Identitas Nama

: Indra Kusuma

NIM

: G2A009128

Tempat, Tanggal lahir

: Rembang, 27 November 1991

Jenis Kelamin

: Laki-laki

Alamat

: Ds. Soditan RT : 03/ II Lasem Kab. Rembang

Nomor Telepon

: (0295) 531306

Nomor HP

: 08811080222

e-mail

: [email protected]

Riwayat Pendidikan Formal 1. SD

: MI-ANNASHRIYAH

Lulus tahun

: 2003

2. SMP

: SMP N 1 LASEM

Lulus tahun

: 2006

3. SMA

: SMA N 2 REMBANG

Lulus tahun

: 2009

4. FK UNDIP : Masuk tahun : 2009

Keanggotaan Organisasi 1. Ketua Jaringan Mahasiswa Kesehatan Indonesia

Tahun 2011 s/d 2012

2. Wakil Ketua Medical Creative Arts

Tahun 2010 s/d 2012

3. Staff Bidang Ekonomi Usaha dan Investasi

Tahun 2010 s/d 2011